| Literature DB >> 27419042 |
Eline H van Roekel1, Elisabeth A H Winkler2, Martijn J L Bours1, Brigid M Lynch3, Paul J B Willems4, Kenneth Meijer4, Ijmert Kant5, Geerard L Beets6, Silvia Sanduleanu7, Genevieve N Healy8, Matty P Weijenberg1.
Abstract
Sedentary behavior (sitting/lying at low energy expenditure while awake) is emerging as an important risk factor that may compromise the health-related quality of life (HRQoL) of colorectal cancer (CRC) survivors. We examined associations of sedentary time with HRQoL in CRC survivors, 2-10 years post-diagnosis. In a cross-sectional study, stage I-III CRC survivors (n = 145) diagnosed (2002-2010) at Maastricht University Medical Center+, the Netherlands, wore the thigh-mounted MOX activity monitor 24 h/day for seven consecutive days. HRQoL outcomes were assessed by validated questionnaires (EORTC QLQ-C30, WHODAS II, Checklist Individual Strength, and Hospital Anxiety and Depression Scale). Confounder-adjusted linear regression models were used to estimate associations with HRQoL outcomes of MOX-derived total and prolonged sedentary time (in prolonged sedentary bouts ≥ 30 min), and usual sedentary bout duration, corrected for waking wear time. On average, participants spent 10.2 h/day sedentary (SD, 1.6), and 4.5 h/day in prolonged sedentary time (2.3). Mean usual sedentary bout duration was 27.3 min (SD, 16.8). Greater total and prolonged sedentary time, and longer usual sedentary bout duration were associated with significantly (P < 0.05) lower physical functioning, and higher disability and fatigue scores. Greater prolonged sedentary time and longer usual sedentary bout duration also showed significant associations with lower global quality of life and role functioning. Associations with distress and social functioning were non-significant. Sedentary time was cross-sectionally associated with poorer HRQoL outcomes in CRC survivors. Prospective studies are needed to investigate whether sedentary time reduction is a potential target for lifestyle interventions aiming to improve the HRQoL of CRC survivors.Entities:
Keywords: BMI, body mass index; CI, confidence interval; CIS, Checklist Individual Strength; CRC, colorectal cancer; Colorectal Neoplasms; EORTC QLQ-C30, European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire-Core 30; EnCoRe study, Energy for life after ColoRectal cancer study; HADS, Hospital Anxiety and Depression Scale; HRQoL, health-related quality of life; ICF, International Classification of Functioning, Disability and Health; MET, metabolic equivalent; MVPA, moderate-to-vigorous physical activity; Quality of Life; SD, standard deviation; Sedentary Lifestyle; Survivors; WHO, World Health Organization; WHODAS II, 12-item World Health Organization Disability Assessment Schedule II; β, unstandardized regression coefficient
Year: 2016 PMID: 27419042 PMCID: PMC4941044 DOI: 10.1016/j.pmedr.2016.06.022
Source DB: PubMed Journal: Prev Med Rep ISSN: 2211-3355
Fig. 1Flow diagram of individuals, diagnosed with stage I–III colorectal cancer at Maastricht University Medical Center+ (2002–2010), who were included into the cross-sectional part of the EnCoRe study and analyses presented in this paper.
Footnotes:
aReasons for non-eligibility are given in order of exclusion, totals do not add up because some exclusion criteria applied concurrently.
bTotals do not add up because some individuals reported multiple reasons for non-participation.
Supplementary Fig. 1Conceptual model, based on the International Classification of Functioning, Disability and Health (ICF), showing relevant factors for studying sedentary time and health-related quality of life outcomes in colorectal cancer survivors that were measured within the cross-sectional part of the EnCore study and included in the current analyses.
Footnotes:
The ICF is a biopsychosocial framework of health and functioning that comprehensively describes and classifies functioning of an individual or a group of individuals in a certain health state by differentiating between body functions and structures, activities, and participation, in the context of environmental and personal factors (barriers/facilitators). Certain health-related quality of life outcomes are shown within multiple ICF domains for functioning (e.g., Physical functioning is shown in both ‘Body functions and Structures’ and ‘Activities’), because meaningful concepts contained in these measures were linked specific ICF categories within these different domains of functioning (e.g., ‘exercise tolerance functions and washing oneself’).
Measurement instruments: aSelf-Administered Comorbidity Questionnaire; bEuropean Organization for the Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30); c12-item World Health Organization Disability Assessment Schedule II (WHODAS II); dChecklist Individual Strength (CIS); eHospital Anxiety and Depression Scale (HADS); fMOX activity monitor (MMOXX1).
Socio-demographic and clinical characteristics of included colorectal cancer survivors (n = 145), diagnosed with stage I–III colorectal cancer at Maastricht University Medical Center+ (2002–2010).
| Characteristic | n | % |
|---|---|---|
| Age, years | ||
| Mean | 70.0 | |
| SD | 8.7 | |
| Years since diagnosis | ||
| Mean | 5.7 | |
| SD | 1.9 | |
| Gender | ||
| Men | 91 | 62.8 |
| Women | 54 | 37.2 |
| Tumor subsite | ||
| Colon | 78 | 53.8 |
| Rectosigmoid | 7 | 4.8 |
| Rectum | 60 | 41.4 |
| Cancer stage | ||
| I | 40 | 29.2 |
| II | 50 | 36.5 |
| III | 47 | 34.3 |
| Treatment with chemotherapy | ||
| Yes | 75 | 51.7 |
| No | 70 | 48.3 |
| Treatment with radiotherapy | ||
| Yes | 55 | 37.9 |
| No | 90 | 62.1 |
| Number of comorbid conditions | ||
| None | 35 | 24.1 |
| 1 | 36 | 24.8 |
| ≥ 2 | 74 | 51.0 |
| Stoma (colostomy/ileostomy) | ||
| Yes | 24 | 16.6 |
| No | 121 | 83.4 |
| BMI, kg/m2 | ||
| Mean | 27.6 | |
| SD | 4.3 | |
| Education level | ||
| Low | 37 | 25.5 |
| Medium | 48 | 33.1 |
| High | 60 | 41.4 |
| Smoking status | ||
| Current | 16 | 11.0 |
| Former | 98 | 67.6 |
| Never | 31 | 21.4 |
| Partner | ||
| Yes | 118 | 81.4 |
| No | 27 | 18.6 |
| Paid employment | ||
| Yes | 24 | 16.6 |
| No | 121 | 83.4 |
Abbreviation: SD, standard deviation.
Data missing for 8 participants.
Descriptive statistics for accelerometer and health-related quality of life (HRQoL) outcome variables in included colorectal cancer survivors (n = 145), diagnosed with stage I–III colorectal cancer at Maastricht University Medical Center+ (2002–2010).
| Characteristic | Mean | SD |
|---|---|---|
| Accelerometer data | ||
| Number of valid days | 6.8 | 0.6 |
| Waking wear time, h/day | 15.3 | 0.8 |
| Sedentary time, h/day | 10.2 | 1.6 |
| Prolonged sedentary time, h/day | 4.5 | 2.3 |
| Usual sedentary bout duration, min | 27.3 | 16.8 |
| Standing time, h/day | 3.4 | 1.2 |
| Physical activity time, h/day | 1.7 | 0.7 |
| HRQoL outcomes (scale) | ||
| Global quality of life (0–100) | 77.6 | 18.3 |
| Physical functioning (0–100) | 80.7 | 20.6 |
| Role functioning (0–100) | 83.4 | 25.3 |
| Social functioning (0–100) | 89.3 | 18.3 |
| Disability (0–100) | 12.5 | 15.6 |
| Fatigue (20–140) | 56.1 | 27.2 |
| Distress (0–42) | 8.3 | 6.0 |
Abbreviation: SD, standard deviation.
Standardized for daily waking wear time using residuals method.
Bout duration at which 50% of total sedentary time is accrued.
Higher scores indicate higher levels of quality of life, physical, role, and social functioning, and disability, fatigue, and distress.
Data missing for 4 participants.
Data missing for 2 participants.
Adjusted results of multivariable linear regression models investigating associations of sedentary time and patterns of sedentary time accumulation with health-related quality of life scoresa in colorectal cancer survivors, diagnosed with stage I–III colorectal cancer at Maastricht University Medical Center+ (2002–2010).
| Global quality of life (n = 137) | Physical functioning (n = 137) | Role functioning (n = 137) | Social functioning (n = 137) | Disability (n = 133) | Fatigue (n = 135) | Distress (n = 135) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI | |
| Sedentary time, per 2 h/day | ||||||||||||||
| Multivariable adjustment | − 2.9 | − 6.8, 1.0 | − 7.4 | − 11.3, − 3.4 | − 4.7 | − 10.1, 0.8 | − 1.6 | − 5.6, 2.5 | 5.5 | 2.5, 8.5 | 8.1 | 2.4, 13.8 | 0.5 | − 0.8, 1.8 |
| With adjustment for physical activity time | − 1.3 | − 6.7, 4.1 | − 5.6 | − 11.2, − 0.1 | − 5.2 | − 12.7, 2.4 | − 2.3 | − 7.9, 3.4 | 5.4 | 1.1, 9.6 | 8.4 | 0.5, 16.3 | − 0.2 | − 2.0, 1.7 |
| Prolonged sedentary time, per 2 h/day | ||||||||||||||
| Multivariable adjustment | − 4.1 | − 6.9, − 1.3 | − 5.7 | − 8.7, − 2.8 | − 4.5 | − 8.5, − 0.5 | − 1.5 | − 4.4, 1.5 | 4.4 | 2.1, 6.6 | 7.1 | 3.1, 11.1 | 0.8 | − 0.1, 1.8 |
| With adjustment for physical activity time | − 4.5 | − 8.2, − 0.9 | − 4.5 | − 8.3, − 0.7 | − 5.3 | − 10.5, − 0.1 | − 2.0 | − 5.8, 1.9 | 4.1 | 1.2, 7.1 | 8.0 | 2.7, 13.2 | 0.7 | − 0.5, 1.9 |
| Usual sedentary bout duration, per 15 min | ||||||||||||||
| Multivariable adjustment | − 4.5 | − 7.3, − 1.7 | − 5.7 | − 8.7, − 2.7 | − 4.9 | − 8.9, − 0.8 | − 0.8 | − 3.8, 2.2 | 4.5 | 2.2, 6.8 | 7.2 | 3.1, 11.2 | 0.8 | − 0.2, 1.7 |
| With adjustment for physical activity and sedentary time | − 5.0 | − 8.6, − 1.4 | − 3.5 | − 7.2, 0.3 | − 4.6 | − 9.7, 0.6 | − 0.3 | − 4.1, 3.6 | 3.2 | 0.3, 6.0 | 6.1 | 0.8, 11.4 | 0.7 | − 0.5, 2.0 |
Abbreviations: β, unstandardized regression coefficient (representing the difference in mean health-related quality of life score per unit increase of the independent variables); CI, confidence interval.
Higher scores indicate higher levels of quality of life, physical, role, and social functioning, and disability, fatigue, and distress.
Standardized for waking wear time (h/day) using residuals method.
Adjusted for waking wear time (h/day), age (years), gender, number of comorbidities (0/1/≥2), smoking status (current/previous or never), time since diagnosis (years), cancer stage (I/II/III), body mass index (kg/m2), paid employment (yes/no; only models with disability as outcome), partner (yes/no; only models with disability and fatigue as outcome), stoma (yes/no; only models with physical, role, and social functioning, and disability and distress as outcome), tumor subsite (colon/rectum, with rectosigmoid classified as rectum; only models with physical and role functioning, and disability as outcome).
Average time spent in sedentary bouts with ≥ 30 min duration per day.
Bout duration at which 50% of total sedentary time is accrued.